SCHEMBL17840347

SCHEMBL17840347

CCN(C(=O)O)c1ccc(OC)cc1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
BACE1 P56817 3/20 0.46
PPARG P37231 4/20 0.45
HDAC8 Q9BY41 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 3/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HPGD P15428 2/20 0.44
ALDH1A1 P00352 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
NCOR2 Q9Y618 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
PTPN1 P18031 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16050329 0.81 ALDH1A1 (0.46) SMN1; SMN2KDM4EMEN1KMT2AHPGD
SCHEMBL4995900 0.77 ALDH1A1 (0.47) SMN1; SMN2LMNAKDM4EMEN1KMT2A
SCHEMBL17840185 0.76 CHRM3 (0.55) ALDH1A1
SCHEMBL17840186 0.76 CHRM3 (0.55) ALDH1A1
SCHEMBL31393810 0.76 BACE1 (0.47) KEAP1NFE2L2BACE1PPARGHDAC8
SCHEMBL17840128 0.75 CHRM3 (0.59) KDM4E
SCHEMBL28201220 0.75 HSD17B2 (0.51) KEAP1NFE2L2BACE1HDAC8LMNA
SCHEMBL14052395 0.75 KMT2A (0.55) BACE1PPARGHDAC8SMN1; SMN2LMNA
SCHEMBL28565885 0.75 PTPN1 (0.47) KEAP1NFE2L2BACE1PPARGHDAC8
SCHEMBL21734725 0.75 KEAP1 (0.60) KEAP1NFE2L2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828339-B2 Biphenyl derivatives and methods for preparing same DONG-A ST CO., LTD (KR) 2017-11-28 US disclosed
US-20160176816-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME DONG-A ST CO., LTD (KR) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160176816-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME CHRM2, CHRM3, CHRM5 KEAP1 2385/4885NFE2L2 2959/4885BACE1 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.